Thanks @green8, (apologies for the tag, reply not working, again!). I’m so over copy & paste.
There is a lot to like here, & it’s so great to be getting some good coverage.
I truly believe the FDA news sparked the renewed interest in PIQ, it just took a little while as to be expected for DD & I also believe that when analysts looked a bit deeper, they could see what most of us here do as well - grossly undervalued for the IP, & of course upcoming catalysts, & with a technical stock & huge shifts in the DKD/CKD space lately, it’s not a 5 minute job!
A hell of a lot of research & stats to trawl through & not even including new COVID-19 research as an instigator post-viral infection with new cases of CKD/DKD & now diabetes as well.
I don’t even think we will know the true numbers in USA/UK/EU until they are out of lockdown & screening in major labs is a priority again, Cancer is another big one, later diagnosis due to lockdown/telehealth. It doesn’t replace a thorough physical examination & other diagnostic tests.
Our patients we are targeting for PromarkerD are in the very high risk cohort for severe COVID-19. Mass Immunisation will help to reduce the curve of infection rates, but I do believe it will always be around, due to mutation of the virus & tweaking of vaccines necessary. Just like the flu shot annually.
A good resource to read is the National Kidney Foundation website in the USA which is Not for Profit & aligned with Govt, Medical & Advisory Groups. This is information for both Medical Professionals & Patients to access, including latest advice.
https://www.kidney.org/covid-19
Ps. & the APP you can pee on a test strip at home & take a photo to send for results, a great idea & very useful during a pandemic with high risk patients. A positive result is a Red Flag to see your GP/Endocrinologist/Nephrologist for more comprehensive testing. It’s not predictive or the be & end all of diagnosis of CKD/DKD, just sends more patients our way really. This test was developed in Israel. We have a commercial deal in Israel. So I think you can see how these tests work together.
https://www.google.com.au/amp/s/www.cnbc.com/amp/2019/02/22/israeli-startup-turns-cellphone-into-a-testing-lab-for-kidney-disease.html
GLTAH![]()
- Forums
- ASX - By Stock
- Ann: Proteomics International seeks FDA approval for PromarkerD
Thanks @green8, (apologies for the tag, reply not working,...
-
-
- There are more pages in this discussion • 141 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PIQ (ASX) to my watchlist
|
|||||
Last
87.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $113.9M |
Open | High | Low | Value | Volume |
87.0¢ | 87.5¢ | 87.0¢ | $61.57K | 70.75K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1539 | 84.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
88.0¢ | 38101 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 1539 | 0.845 |
1 | 16218 | 0.835 |
1 | 2000 | 0.830 |
3 | 6100 | 0.825 |
2 | 4865 | 0.820 |
Price($) | Vol. | No. |
---|---|---|
0.880 | 38101 | 2 |
0.885 | 495 | 1 |
0.890 | 13245 | 1 |
0.900 | 12952 | 2 |
0.910 | 3200 | 1 |
Last trade - 10.35am 15/08/2024 (20 minute delay) ? |
Featured News
PIQ (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online